Journals / Klimik Dergisi / 2012 / Cilt: 25 - Sayı: 1

Penicillin susceptibility of viridans group streptococci isolated from the oropharynx of patients with hematological malignancy

Hematolojik kanserli hastaların orofarinksinden izole edilen viridans grubu streptokoklarda penisilin duyarlılığı

Pages
6–9
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is important to design larger studies to determine a therapeutic guideline based on local data for patients with hematological malignancies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The objective of this study is to determine the susceptibility to penicillin and teicoplanin of viridans group streptococci (VGS) isolated from the oropharynx of patients with hematological malignancies and to assess the risk factors for penicillin resistance.
📊
Key Findings & Data:Methods: This prospective cohort study was conducted between January 2007 and December 2008 in patients with hematological malignancies.
💡
Conclusion & Impact:It is important to design larger studies to determine a therapeutic guideline based on local data for patients with hematological malignancies.
🔬Design:Research Article
📍Scope:2007 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The objective of this study is to determine the susceptibility to penicillin and teicoplanin of viridans group streptococci (VGS) isolated from the oropharynx of patients with hematological malignancies and to assess the risk factors for penicillin resistance. Methods: This prospective cohort study was conducted between January 2007 and December 2008 in patients with hematological malignancies. Oropharyngeal cultures were obtained and risk factors for reduced susceptibility to penicillin of VGS were analyzed. Results: VGS were isolated from the oropharynx in 75 of 122 patients. Penicillin minimum inhibitor concentration (MIC) range was 0.047-3.0 mg/L. Thirty-two (42.7%) isolates were susceptible to penicillin. High-level penicillin resistance (MIC ≥4 mg/L) was determined in none of the isolates. However, 43 (57.3%) of the isolates had reduced susceptibility to penicillin. Teicoplanin MIC range was 0.047-0.94 mg/L. Type and duration of hematological malignancy, presence of comorbidities, previous hospitalization within a year, length of hospital stay, antibiotic use within the previous six months, immunosuppressive drugs, and smoking were not a risk factor for reduced susceptibility to penicillin. Conclusions: The determination of antibiotic susceptibility of VGS in the oropharyngeal flora has significant implications for empirical therapy of the infections in patients with hematological malignancies. It is important to design larger studies to determine a therapeutic guideline based on local data for patients with hematological malignancies.

Özet

Amaç: Bu çalışmada, hematolojik kanserli hastaların, orofarinksinden izole edilen viridans grubu streptokok (VGS) lardaki penisilin ve teikoplanin duyarlılığının araştırılması ve penisilin direnci için risk faktörlerinin belirlenmesi amaçlanmıştır. Yöntemler: Bu prospektif kohort çalışması, hematolojik kanserli hastalarda, Ocak 2007-Aralık 2008 tarihleri arasında yürütüldü. Hastaların orofarinks kültürleri alındı ve izole edilen VGSlerdeki azalmış penisilin duyarlılığı için risk faktörleri incelendi. Bulgular: 122 hastanın 75inin orofarinksinden VGS izole edildi. VGSlerin penisilin minimum inhibitör konsantrasyonu (MİK) 0.047-3 mg/lt olarak saptandı. Bunların 32 (%42.7)si penisiline duyarlı bulundu. Hiçbir izolatta penisiline karşı yüksek düzey direnç (MİK ≥4 mg/lt) saptanmazken, 43 (%57.3)ünde penisiline azalmış duyarlılık saptandı. Teikoplanin MİK değerleri 0.047-0.94 mg/lt olarak bulundu. Kanser tipi, kanser süresi, eşlik eden hastalıklar, son bir yıl içinde hastanede yatma öyküsü, hastanede yatış sayısı, son altı ay içinde antibiyotik kullanımı, bağışıklığı baskılayıcı tedaviler ve sigara kullanımı gibi risk faktörlerinin hiçbiri azalmış penisilin duyarlılığıyla ilişkili bulunmadı. Sonuçlar: Hematolojik kanserli hastaların orofarinks florasında yer alan VGSlerin antibiyotik duyarlılıklarının bilinmesi, ampirik tedavinin belirlenmesinde önemlidir. Ülkemiz verilerine göre hematolojik kanserli hastalardaki tedavi kılavuzlarını belirleyebilmek için, daha kapsamlı çalışmaların yapılması yararlı olacaktır.

🔖

Cite This Article

ÖKKE, D., TEPELİ, E., DEMİR, M., SARI, İ., SAYIN, S. K. (2022). Penicillin susceptibility of viridans group streptococci isolated from the oropharynx of patients with hematological malignancy. Klimik Dergisi, Cilt: 25 - Sayı: 1, 6–9. https://ajindex.com/articles/573652

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Tunkel AR, Sepkowitz KA. Infections caused by viridans streptococci in patients with neutropenia. Clin Infect Dis. 2002
  2. 34(11): 1524-9. [CrossRef] 2. Huang WT, Chang LY, Hsueh PR, et al. Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients. J Microbiol Immunol Infect. 2007
  3. 40(4): 349-54. 3. Bruckner L, Gigliotti F. Viridans group streptococcal infections among children with cancer and the importance of emerging antibiotic resistance. Semin Pediatr Infect Dis. 2006
  4. 17(3): 153-60. [CrossRef] 4. Alcaide F, Benítez MA, Carratalà J, Gudiol F, Liñares J, Martín R. In vitro activities of the new ketolide HMR 3647 (telithromycin) in comparison with those of eight other antibiotics against viridans group streptococci isolated from blood of neutropenic patients with cancer. Antimicrob Agents Chemother. 2001
  5. 45(2): 624-6. [CrossRef] 5. Paganini H, Staffolani V, Zubizarreta P, Casimir L, Lopardo H, Luppino V. Viridans streptococci bacteraemia in children with fever and neutropenia: a case-control study of predisposing factors. Eur J Cancer. 2003
  6. 39(9): 1284-9. [CrossRef] 6. Wisplinghoff H, Reinert RR, Cornely O, Seifert H. Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients. J Clin Microbiol. 1999
  7. 37(6): 1876-80. 7. Presterl E, Grisold AJ, Reichmann S, Hirschl AM, Georgopoulos A, Graninger W. Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics. J Antimicrob Chemother. 2005
  8. 55(1): 45-50. [CrossRef] 8. Alcaide F, Carratala J, Liñares J, Gudiol F, Martin R. In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients. Antimicrob Agents Chemother. 1996
  9. 40(9): 2117-20. 9. Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Disease Society of America. Clin Infect Dis. 2011
  10. 52(4): e56-93. [CrossRef] 10. Febril Nötropeni Çalışma Grubu. Febril nötropenik hastalarda tanı ve tedavi kılavuzu. Flora. 2004
  11. 9(1): 5-28. 11. Facklam R. What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin Microbiol Rev. 2002
  12. 15(4): 613-30. [CrossRef] 12. Clinical and Laboratory Standards Institute. Performance S